Anavex Life Sciences Corporation (NASDAQ:AVXL) currently has a daily average trading volume of 935.80K but it saw 1465321 shares traded in last market. With a market cap of 902.38M USD, the company’s current market price of $10.57 came rising about 13.29 while comparing to the previous closing price of $9.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.44 and as low as $4.00. In the recent trading on the day, stock has struck highest price mark of $9.25 while lowest mark touched by it was $10.755.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which downgraded the stock as “Neutral” in its note to investors issued on December 06, 2022, recommending a price target of between $16 and $11 for it. BTIG Research issued its recommendations for the stock as it initiated the price target for the stock is $35.
Over the week, AVXL’s stock price is moving 12.33% up while it is 39.81% when we observe its performance for the past one month. Year-to-date it is 150.47% up and over the past year, the stock is showing a downside performance of -1.58%.
Currently, Anavex Life Sciences Corporation’s total number of outstanding shares is 85.33M. Company’s return on investment (ROI) stands at -47.26% and return on equity (ROE) at -40.13%. It has a 7.51 of forward P/E ratio. Stock’s beta reads 0.79. Stock has a price to book (P/B) ratio of 9.04. Its return on asset (ROA) is -36.00% on average.
#
